EUVIMEDEUVIMED entdecken
CrossrefInfokarte

A Comparison of Imaging Techniques to Monitor Tumor Growth and Cancer Progression in Living Animals

Anne-Laure Puaux, Lai Chun Ong, Yi Jin, Irvin Teh, Michelle Hong, Pierce K. H. Chow, Xavier Golay, Jean-Pierre Abastado

International Journal of Molecular Imaging · 2011

DOI: 10.1155/2011/321538 ↗
AbstractBibliografische Angaben

Abstract

Introduction and Purpose . Monitoring solid tumor growth and metastasis in small animals is important for cancer research. Noninvasive techniques make longitudinal studies possible, require fewer animals, and have greater statistical power. Such techniques include FDG positron emission tomography (FDG-PET), magnetic resonance imaging (MRI), and optical imaging, comprising bioluminescence imaging (BLI) and fluorescence imaging (FLI). This study compared the performance and usability of these methods in the context of mouse tumor studies. Methods . B16 tumor-bearing mice ( n = 4 for each study) were used to compare practicality, performance for small tumor detection and tumor burden measurement. Using RETAAD mice, which develop spontaneous melanomas, we examined the performance of MRI ( n = 6 mice) and FDG-PET ( n = 10 mice) for tumor identification. Results . Overall, BLI and FLI were the most practical techniques tested. Both BLI and FDG-PET identified small nonpalpable tumors, whereas MRI and FLI only detected macroscopic, clinically evident tumors. FDG-PET and MRI performed well in the identification of tumors in terms of specificity, sensitivity, and positive predictive value. Conclusion . Each of the four methods has different strengths that must be understood before selecting them for use.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →